未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Cardiovascular, renal, and lower limb outcomes in patients with type 2 diabetes after percutaneous coronary intervention and treated with sodium-glucose cotransporter 2 inhibitors vs. dipeptidyl peptidase-4 inhibitors
Lee, Hsin-Fu; Chan, Yi-Hsin; Chuang, Chi; Li, Pei-Ru; Yeh, Yung-Hsin; Hsiao, Fu-Chih; Peng, Jian-Rong; See, Lai-Chu
分享
收藏
分享
收藏
分享
收藏
分享
收藏The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study接受钠葡萄糖cotransporter-2抑制剂、胰高血糖素样肽-1受体激动剂和二肽基peptidase-4抑制剂治疗的2型糖尿病患者发生房颤的风险: 一项全国性队列研究
Chan, Yi-Hsin; Chao, Tze-Fan; Chen, Shao-Wei; Lee, Hsin-Fu; Li, Pei-Ru; Chen, Wei-Min; Yeh, Yung-Hsin; Kuo, Chi-Tai; See, Lai-Chu; Lip, Gregory Y. H.
分享
收藏
分享
收藏
分享
收藏